Pre-exposure prophylaxis with 300 mg Evusheld elicits limited neutralizing activity against the Omicron variant

Detalles Bibliográficos
Autores principales: Benotmane, Ilies, Velay, Aurélie, Gautier-Vargas, Gabriela, Olagne, Jérôme, Thaunat, Olivier, Fafi-Kremer, Samira, Caillard, Sophie
Formato: Online Artículo Texto
Lenguaje:English
Publicado: International Society of Nephrology. Published by Elsevier Inc. 2022
Materias:
Letter to the Editor
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9126611/
https://www.ncbi.nlm.nih.gov/pubmed/35618094
http://dx.doi.org/10.1016/j.kint.2022.05.008

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9126611/
https://www.ncbi.nlm.nih.gov/pubmed/35618094
http://dx.doi.org/10.1016/j.kint.2022.05.008

Ejemplares similares